Uncategorized

Palliative Care in Gynecologic CancerIntegrating symptom relief and quality of life throughout the cancer journey   Napas Lohtrakul, MDDepartment of Obstetrics and Gynecology, Phramongkutklao Hospital            Advances in gynecologic oncology have expanded therapeutic options and prolonged survival, but more treatment does not automatically reduce symptom burden or decisional burden. Patients may experience…

HPV Vaccination: Clinical Update for Healthcare Providers Assoc.Prof.Tanitra Tantitamit, MD.Department of Obstetrics and GynocologyFaculty of medicine, Srinakharinwirot University         This concise review current clinical data and Royal Thai College of Obstetricians and Gynaecologists (RTCOG) guidelines to optimize HPV immunization strategies in clinical practice. Current Status of HPV-Related Cancers in ThailandCervical cancer remains…

Molar Pregnancy and Choriocarcinoma: What You Need to Know Panida Mathaveechotikul, MD.Gynecologic Oncology UnitDepartment of Obstetrics and Gynecology, Ramathibodi Hospital            Molar pregnancy and choriocarcinoma are caused by pregnancy abnormalities. Their incidence rates vary worldwide, with the highest numbers in Asia. In Thailand, reports show that molar pregnancy occurs in about…

Asst. Prof. Jakapan Khunnarong, M.D.Faculty of Medicine Vajira Hospital, Navamindradhiraj University          When discussing cancer in women, most people immediately think of “breast cancer” or “cervical cancer,” which are widely recognized due to extensive public awareness and routine screening campaigns. In reality, however, another gynecological malignancy is experiencing a sharp rise in…

Role of Hyperthermic Intraperitoneal Chemotherapy in Gynecologic Cancer Treatment Asst.Prof. Marut Yanaranop, MD, PhDGynecologic Oncology Unit, Department of Obstetrics and Gynecology, Rajavithi Hospital          Cancers with peritoneal metastases including ovarian cancer, gastric cancer, and appendiceal cancer is generally associated with a poor prognosis and limited responsiveness to systemic chemotherapy (1). Hyperthermic intraperitoneal…

Strategic Directions in Overcoming Platinum-Resistant Ovarian Cancer: A Paradigm Shift Asst.Prof. Yuthasak SuphasynthDepartment of Obstetrics and Gynaecology,Faculty of Medicine, Prince of Songkla University           For decades, the management of Platinum-Resistant Ovarian Cancer (PROC) has been constrained by a therapeutic plateau, where sequential non-platinum chemotherapy (weekly paclitaxel, PLD, gemcitabine, or topotecan) with…

Postmenopausal Bleeding: Clinical Approach and Management Khemanat Khemaworapong, MD, Asst. Prof. Bunlert Wiriyapak, MDDepartment of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital              Postmenopausal Bleeding (PMB) is a common gynecological issue encountered in general practice, accounting for approximately 5% of all gynecological visits. It is clinically defined as vaginal…

Hereditary Gynecologic Cancers: What Clinicians Should Recognize in Daily Practice Sopita Prasertpakdi, M.D. Asst.Prof. Kittipat Charoenkwan, M.D.Division of Gynecologic Oncology, Department of Obstetrics and Gynecology,Faculty of Medicine, Chiang Mai University, Thailand Why hereditary gynecologic cancer matters?          Gynecologic cancers represent a major health burden among women worldwide. While most cases arise sporadically,…

Behavioral Modification and Health Care After Gynecologic Cancer Treatment  Gp.Capt. Piyawan Pariyawateekul, Flt.Lt Pichamon Sukkasame Department of Obstetrics and Gynecology, Bhumibol Adulyadej Hospital            The diagnosis of gynecologic cancer, e.g. ovarian cancer, cervical cancer, or endometrial cancer, is considered a major turning point in the woman’s life. Intensive cancer treatments, as surgery, chemotherapy, or radiation therapy, may…